scispace - formally typeset
A

Achille P. Caputi

Researcher at University of Messina

Publications -  407
Citations -  19416

Achille P. Caputi is an academic researcher from University of Messina. The author has contributed to research in topics: Nitrotyrosine & Artery occlusion. The author has an hindex of 74, co-authored 405 publications receiving 18740 citations. Previous affiliations of Achille P. Caputi include Queen Mary University of London & University of Salerno.

Papers
More filters
Journal ArticleDOI

Beneficial effects of GW274150, a novel, potent and selective inhibitor of iNOS activity, in a rodent model of collagen-induced arthritis

TL;DR: It is provided the first evidence that GW274150, a novel, potent and selective inhibitor of iNOS activity, attenuates the degree of chronic inflammation and tissue damage associated with collagen-induced arthritis in mice.
Journal ArticleDOI

Interaction between fluvoxamine and imipramine/desipramine in four patients.

TL;DR: Observations indicate that fluvoxamine inhibits both the demethylation of imipramine and, possibly to a lesser extent, the hydroxylation of desipramines, which indicates that the combination of fluVoxamine with tricyclic antidepressants should be avoided whenever possible.
Journal ArticleDOI

Beneficial effects of tempol, a membrane-permeable radical scavenger, on the multiple organ failure induced by zymosan in the rat.

TL;DR: This study provides the first evidence that tempol, a small molecule that permeates biological membranes and scavenges reactive oxygen species, attenuates the degree of MOF associated with zymosan-induced peritonitis in the rat.
Journal Article

Role of interleukin-6 in a non-septic shock model induced by zymosan.

TL;DR: It is demonstrated that IL-6 exerts a role in zymosan-induced non-septic shock and in vivo treatment with anti-IL-6 significantly reduced the inflammatory process.
Journal ArticleDOI

Protective effects of M40403, a superoxide dismutase mimetic, in a rodent model of colitis

TL;DR: The results of this study suggested that administration of a superoxide dismutase mimetic may be beneficial for treatment of inflammatory bowel disease.